0
0
0
Cutting Medicare Prescription Drug Prices in Half Act
12/29/2022, 9:18 PM
Congressional Summary of S 3615
Cutting Medicare Prescription Drug Prices in Half Act
This bill caps the cost of prescription drugs under Medicare at the amount that the Department of Veterans Affairs or the General Services Administration pays for the drug, whichever is lower.
Read the Full Bill
Current Status of Bill S 3615
Bill S 3615 is currently in the status of Bill Introduced since February 9, 2022. Bill S 3615 was introduced during Congress 117 and was introduced to the Senate on February 9, 2022. Bill S 3615's most recent activity was Read twice and referred to the Committee on Finance. as of February 9, 2022
Bipartisan Support of Bill S 3615
Total Number of Sponsors
1Democrat Sponsors
0Republican Sponsors
0Unaffiliated Sponsors
1Total Number of Cosponsors
1Democrat Cosponsors
1Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill S 3615
Primary Policy Focus
HealthAlternate Title(s) of Bill S 3615
Cutting Medicare Prescription Drug Prices in Half Act
Cutting Medicare Prescription Drug Prices in Half Act
A bill to establish a cap on costs for covered prescription drugs under Medicare parts B and D.
Comments
Sponsors and Cosponsors of S 3615
Latest Bills
CLEAN Act
Bill HR 1687July 31, 2026
CLEAN Act
Bill S 4960July 31, 2026
Biosimilar Red Tape Elimination Act
Bill S 1954July 31, 2026
Summer Meals REACH Act of 2026
Bill HR 9587July 31, 2026
Kayleigh’s Law Act of 2026
Bill HR 8481July 31, 2026
Cannabis Administration and Opportunity Act
Bill S 5022July 31, 2026
Duster Inhalation Prevention Act
Bill S 5002July 31, 2026
ACCESS Rural America Act
Bill S 5003July 31, 2026
License to Drill Act
Bill HR 7831July 31, 2026
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Health and Human Services relating to "Restoring Flexibility in the Child Care and Development Fund (CCDF)".
Bill SJRES 199July 31, 2026

